Carmell Therapeutics Corp - US shares owned by Vanguard Group
Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Carmell Therapeutics Corp - US
Tip: Access up to 7 years of quarterly data
All positions including Carmell Therapeutics Corp - US held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Carmell Therapeutics Corp - US by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $242k | 182k | 1.33 |
| 2024-03-31 | $442k | 173k | 2.56 |
| 2023-12-31 | $646k | 170k | 3.81 |
| 2023-09-30 | $583k | 162k | 3.60 |
Top funds holding Carmell Therapeutics Corp - US
View all funds holding Carmell Therapeutics Corp - US